According to the National Cancer Institute, in 2016, an estimated 1,685,210 new cases of cancer will be diagnosed in the United States and 595,690 people will die from the disease.
The most common cancers in 2019 are projected to be breast cancer, lung and bronchus cancer, prostate cancer, colon and rectum cancer, bladder cancer, melanoma of the skin, non-Hodgkin lymphoma, thyroid cancer, kidney and renal pelvis cancer, leukemia, endometrial cancer, and pancreatic cancer.
We know that treating patients with cancer is not a one-size-fits all approach. That is why HF Healthcare provides a manageable care plan that works in concert with your physician and insurance payer. We are here to guide oncology patients to a healthy future!
- Abraxane
- Afinitor
- Alecensa
- Arimidex
- Aromasin
- Arranon
- Arzera
- Avastin
- Bendamustine
- Bendeka
- Blincyto
- Cotellic
- Dacogen (decitabine)
- Darzalex
- Eligard
- Erbitux
- Erivedge
- Farydak
- Fimagon
- Folotyn
- Gazyva
- Gleevee
- Halaven
- Herceptin
- Hycamtin
- Intron A
- Istodax
- Jevtana
- Kadcyla
- Kepivance
- Keytruda
- Kisqali
- Kisqali Femura
- Lupron Depot
- Matulane
- Mekinist
- Ninlaro
- Odom zo
- Opdivo
- Pegasys
- Pomalyst
- Portrazza
- Proleukin
- Promacta
- Provenge
- Revlimid
- Rituaxan
- Rydap
- Sprycel
- Sylvant
- Tafinlar
- Tamoxifen
- Tarceva
- Targretin
- Tasigna
- Tecentriq
- Temodar
- Thalomid
- Torisel
- Treanda
- Tykerb
- Vectibix
- Velcade
- Vidaza
- Votrient
- Xeloda
- Xgeva
- Yervoy
- Yondelis
- Yonsa
- Zelboraf
- Zoladex
- Zolinza
- Zytiga
Last page update: 06/07/19 at 10:08am